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Computational Design of β-Fluorinated Morphine Derivatives
for pH-specific Binding
By: Makena Augenstein, Nayiri Alexander, and Dr. Matthew Gartner
Schmid College of Science and Technology, Chapman University

Morphine Binding
In 2019, over 10 million Americans aged 12 and older
1
abused opioids . Opioids are highly effective pain
medications with dangerous side effects, such as
addiction. Opioids currently bind indiscriminately to
both central and peripheral μ-opioid receptors (MOR).
Side effects result from central activation. There is no
opioid capable of selective binding within peripheral
nerves.

Computational Design of Experimental Morphine Derivatives
Structures were built within the graphical interface Gaussview6. Electronic structure calculations were submitted with Gaussian16 to the Keck Computational Research
Cluster at Chapman University. Structures were optimized using M06-2X(SMD)/aug-cc-pVDZ level of theory.
(1) ΔGaq= Gaq(Morphine) – Gaq(Morphine-H+) + Gaq(H+)

(2)

Theoretical pKa were calculated with the direct calculation method (Eq. 2) and change in Gibbs free energy values ( ΔGaq ) from (1). Percent protonation calculations
were executed with the Henderson-Hasselbalch equation. Molecular modeling was performed with Maestro: Schrödinger to visualize protein-ligand interaction with
Asp147 and Tyr148 residues of the MOR (PDB ID: 4DKL). The experimental derivatives were superimposed on ligand BFO 601.

Effects of Morphine Modifications on pH Selectivity and Interactions

Fig. 1: The 2D chemical structure of morphine.

Activation depends on the ion pair bond between the
147
negatively charged carboxylate of Asp and the
protonated tertiary amine group on the opioid. Morphine
is protonated within physiological pH conditions
(pH=7.4) and can bind in all tissues.2 Inflamed tissue is
more acidic (pH=6-6.5); this discrepancy in pH
conditions leads to new opportunity for a novel opioid to
bind preferentially in lower pH environments. Structural
changes to morphine leads to selective binding, such as
the addition of a fluorine atom at a β-carbon site from the
amine. Fluorination decreases the pKa via induction.
Additionally, removal of C and D rings allow for greater
flexibility when binding (Fig. 1). Subsequent removal of
the hydroxyl group from the A ring maximizes the pain
relief response.
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Fig. 3: Intermolecular interactions between fluoromorphine derivatives within the 4KDL
MOR shown in 2D of (A) morphine and (B) Dehydroxy-fluoromorphine β-C2.

Fig. 2: Structural modifications made to protonated morphine resulting in the experimental derivatives. (A-C) depict C and D ring dissection. (D-F)
depict ring dissection and hydroxyl group removal. Fluorination at various beta carbon sites are visualized or all experimental derivatives.

Derivatives preferentially bind in sites of peripheral
inflammation, while discouraging binding within central
tissues. These results raise exciting possibilities for
medication that is capable of providing pain relief, without
the addiction risk of current opioids.

A novel morphine derivative is designed that binds
specifically within peripheral MORs of inflamed
conditions and avoids activation in healthy
tissue–the brain– that leads to addiction.

Fluoromorphine β-C1, Dehydroxy-fluoromorphine β-C2, and Dehydroxy-fluoromorphine β-C3–depict
increased binding in inflamed tissue and decreased in healthy tissue. Fluorination successfully lowered the
pKa values of the derivatives within the acidic tissue range. Percent protonation is reduced in healthy tissue
while remaining high in inflamed tissue. The dissected structures maintain interactions needed for pain
relief response and the modeled interactions depict a pi-cation bond between the protonated amine and
aromatic ring on Tyr148. This novel bond is potentially vital to binding affinity and specificity. In vivo
studies discovered an unfavorable bond between the A ring hydroxyl group and His297 that adversely
affects pain relief delivery in inflamed tissue. Removal of the hydroxyl group avoids this interaction.
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Fig. 4: 3D optimized interactions between Asp147 and Tyr148 of the MOR and
morphine (A) and Fluoromorphine β-C1 (B).
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In 2019, over 10 million Americans aged 12 and older
abused opioids1. Opioids are highly effective pain
medications with dangerous side effects, such as
addiction. Opioids currently bind indiscriminately to
both central and peripheral μ-opioid receptors (MOR).
Side effects result from central activation. There is no
opioid capable of selective binding within peripheral
nerves.

Structures were built within the graphical interface Gaussview6. Electronic structure calculations were
submitted with Gaussian16 to the Keck Computational Research Cluster at Chapman University.
Structures were optimized using M06-2X(SMD)/aug-cc-pVDZ level of theory.
(2)

(1) ΔGaq= Gaq(Morphine) – Gaq(Morphine-H+) + Gaq(H+)

Theoretical pKa were calculated with the direct calculation method (Eq. 2) and change in Gibbs free
energy values (ΔGaq ) from Reaction 1. Percent protonation calculations were executed with the
Henderson-Hasselbalch equation. Molecular modeling was performed with Maestro: Schrödinger to
visualize protein-ligand interaction with Asp147 and Tyr148 residues of the MOR (PDB ID: 4DKL). The
experimental derivatives were superimposed on ligand BFO 601.
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Fig. 3: Intermolecular interactions between fluoromorphine derivatives within the
4KDL MOR shown in 2D of (A) morphine and (B) Dehydroxy-fluoromorphine
β-C2.

Fig. 1: The 2D chemical structure of the morphine molecule with rings labeled
A-E. The protonable binding site on the tertiary amine allows for binding..

Activation depends on the ion pair bond between the
negatively charged carboxylate of Asp147 and the
protonated tertiary amine group on the opioid. Morphine
is protonated within physiological pH conditions
2
(pH=7.4) and can bind in all tissues. Inflamed tissue is
more acidic (pH=6-6.5); this discrepancy in pH
conditions leads to new opportunity for a novel opioid to
bind preferentially in lower pH environments. Structural
changes to morphine leads to selective binding, such as
the addition of a fluorine atom at a β-carbon site from the
amine. Fluorination decreases the pKa via induction.
Additionally, removal of C and D rings allow for greater
flexibility when binding (Fig. 1). Subsequent removal of
the hydroxyl group from the A ring maximizes the pain
relief response.
A novel morphine derivative is designed that binds
specifically within peripheral MOR of inflamed
conditions and avoids activation in healthy
tissue–the brain– that leads to addiction.
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Fig. 4: 3D optimized interactions between Asp147 and Tyr148 of the MOR and
morphine (A) and Fluoromorphine β-C1 (B).

Fig. 2: Structural modifications of protonated morphine along with the experimental morphine derivatives. Fluoromorphine β-C1, Fluoromorphine
β-C2, and Fluoromorphine β-C3 depict C and D ring dissection. Dehydroxy-fluoromorphine β-C1, Dehydroxy-fluoromorphine β-C2, and
Dehydroxy-fluoromorphine β-C3 depict ring dissection and hydroxyl group removal from the A ring of morphine. Fluorination at various beta carbon
sites are visualized in the chemical structures for all experimental derivatives.

The modeled interactions contribute to the favorability of
these derivatives. The pi-cation bond between the protonated
148
amine and aromatic ring on Tyr is novel and potentially
vital to binding affinity and specificity. The dissected
structures maintain important interactions while eliminating
bulky rings. In vivo studies discovered an unfavorable bond
between the A ring hydroxyl group and His297. They suggest
hydroxyl group removal as it adversely affects pain
relief.delivery in acidic conditions.
Derivatives preferentially bind in sites of peripheral
inflammation, while discouraging binding within central
tissues. These results raise exciting possibilities for
medication that is capable of providing pain relief, without
the addiction risk of current opioids.
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